午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2)

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2) Struktur
2802202-55-5
CAS-Nr.
2802202-55-5
Englisch Name:
5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2)
Synonyma:
2-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-5-amine;2-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-5-amine dihydrochloride;2-methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-5-amine dihydrochloride;5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2)
CBNumber:
CB813233277
Summenformel:
C7H12ClN3
Molgewicht:
173.64
MOL-Datei:
2802202-55-5.mol

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2) Eigenschaften

Sicherheit

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2) Chemische Eigenschaften,Einsatz,Produktion Methoden

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd. 		+86-512-68323658 +86-18168183658
 sales1@artkmedchem.com China 39004 58
Xi'an Kaixin Biotechnology Co., Ltd 029-68881181 13619217766
 3495811982@qq.com China 2771 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
 sales@pharmablock.com China 7268 58
Huanuo Pharmaceutical Technology (Guangxi) Co., Ltd 13005928603
 211017228@qq.com China 6658 58
  • 5-Cyclopentapyrazolamine, 2,4,5,6-tetrahydro-2-methyl-, hydrochloride (1:2)
  • 2-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-5-amine
  • 2-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-5-amine dihydrochloride
  • 2-methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazol-5-amine dihydrochloride
  • 2802202-55-5
Copyright 2019 ? ChemicalBook. All rights reserved